A Case of Surreptitious Glargine Overdose Confirmed by Insulin Pharmacokinetic Time Curves

被引:2
作者
Barmanray, Rahul [1 ]
Chiang, Cherie Ying [1 ,2 ,3 ]
Yeoh, Kim [4 ]
Yates, Christopher James [1 ,2 ]
机构
[1] Royal Melbourne Hosp, Dept Diabet & Endocrinol, Melbourne, Vic, Australia
[2] Univ Melbourne, Dept Med, Melbourne, Vic, Australia
[3] Royal Melbourne Hosp, Dept Pathol, Melbourne, Vic, Australia
[4] Royal Melbourne Hosp, Dept Med, Melbourne, Vic, Australia
关键词
CROSS-REACTIVITY; ANALOGS;
D O I
10.1093/jat/bkz025
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Case: A 49-year-old man presented with recurrent altered conscious state suggestive of encephalitis. This was followed by an episode of severe hypoglycemia requiring protracted intravenous glucose administration. Comparing the pharmacokinetic time curves of serum insulin levels on two insulin immunoassays with different insulin analog cross-reactivity allowed the likely diagnosis of surreptitious glargine overdose to be made rapidly. Discussion: The differing insulin analog cross-reactivity of serum insulin immunoassays, in this case the Abbott ARCHITECT and Roche Elecsys, allows the presence of insulin analog to be detected. Through comparison of time curves the characteristic signature of the specific causative insulin analog can be identified. This information confirms surreptitious insulin overdose in a timely manner, therefore avoiding the expensive and time-consuming investigations required to exclude alternate causes of severe hypoglycemia.
引用
收藏
页码:E4 / E6
页数:3
相关论文
共 8 条
[1]   Glargine blood biotransformation: in vitro appraisal with human insulin immunoassay [J].
Agin, A. ;
Jeandidier, N. ;
Gasser, F. ;
Grucker, D. ;
Sapin, R. .
DIABETES & METABOLISM, 2007, 33 (03) :205-212
[2]   Intentional overdose with insulin glargine [J].
Ashawesh, Khaled ;
Padinjakara, Rayin N. Kulambil ;
Murthy, Narasimha P. ;
Nizar, Hisham ;
Anwar, Aresh .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2009, 66 (06) :534-534
[3]   Prolonged glucose requirements after intentional glargine and aspart overdose [J].
Fromont, I. ;
Benhaim, D. ;
Ottomani, A. ;
Valero, R. ;
Molines, L. ;
Vialettes, B. .
DIABETES & METABOLISM, 2007, 33 (05) :390-392
[4]   OCTREOTIDE FOR THE TREATMENT OF HYPOGLYCEMIA AFTER INSULIN GLARGINE OVERDOSE [J].
Groth, Christine M. ;
Banzon, Eleanor R. .
JOURNAL OF EMERGENCY MEDICINE, 2013, 45 (02) :194-198
[5]   Extensive study of human insulin immunoassays: promises and pitfalls for insulin analogue detection and quantification [J].
Heurtault, Beatrice ;
Reix, Nathalie ;
Meyer, Nicolas ;
Gasser, Francoise ;
Wendling, Marie-Josee ;
Ratomponirina, Charline ;
Jeandidier, Nathalie ;
Sapin, Remy ;
Agin, Arnaud .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2014, 52 (03) :355-362
[6]   LANTUS INSULIN OVERDOSE: A CASE REPORT [J].
Lu, Michael ;
Charles, Pholaphat .
JOURNAL OF EMERGENCY MEDICINE, 2011, 41 (04) :374-377
[7]   Performance evaluation and cross-reactivity from insulin analogs with the ARCHITECT insulin assay [J].
Moriyama, Masako ;
Hayashi, Nobuhide ;
Ohyabu, Chinami ;
Mukai, Masahiko ;
Kawano, Seiji ;
Kumagai, Shunichi .
CLINICAL CHEMISTRY, 2006, 52 (07) :1423-1426
[8]   Cross-reactivity of three recombinant insulin analogs with five commercial insulin immunoassays [J].
Owen, WE ;
Roberts, WL .
CLINICAL CHEMISTRY, 2004, 50 (01) :257-259